No abstract
Curr Diab Rep. 2026 Mar 10;26(1):5. doi: 10.1007/s11892-026-01619-4.
NO ABSTRACT
PMID:41806022 | DOI:10.1007/s11892-026-01619-4
Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes : Incretin Therapy in T2DM and PAD
Scritto il 10/03/2026
da Larissa Araújo de Lucena